Clinical, endocrine, and metabolic effects of acarbose, a α-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1144-1148

  Tuǧrul, Semih ^a   Kutlu, Tayfun ^a   Pekin, Oya ^a   Baǧlam, Elif ^a   Kiyak, Hüseyin ^a   Oral, Özay ^a  

^a Zeynep Kamil Teaching Hospital   (Turkey)

Author keywords

Acarbose; hyperinsulinemia; PCOS

Indexed keywords

ACARBOSE; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ACARBOSE; ADULT; ALPHA-GLUCOSIDASES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; OBESITY; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME;

EID: 52949100161     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.07.1326     Document Type: Article

References (16)

1. Franks S. Polycystic ovary syndrome. N Eng J Med 333 (1995) 853-861
2. Nestler J.E. Role of the hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome and its clinical implications. Semin Reprod Endocrinol 15 (1997) 111-122
3. Dunaif A., Scott D., Finegood D., Quintana B., and Whitcomb R. The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Endocrinol Metab 81 (1996) 3299-3306
4. Ehrmann D.A. Insulin-lowering therapeutic modalities for poly-cystic ovary syndrome. Endocrinol Metab Clin North Am 28 (1999) 423-438
5. Nestler J.E., and Jacubowicz D. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335 (1996) 617-623
6. Legro R.S., Kunselman A.R., Donson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
7. Velazquez E.M., Mendoza S., Hamer T., Sosa F., and Glueck C.J. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43 (1994) 647-654
8. Geisthovel F., Frorath B., and Brabant G. Acarbose reduces elevated testosterone serum concentrations in hyperinsuliaemic premenopausal women: a pilot study. Hum Reprod 11 (1996) 2377-2381
9. Ciotta L., Calogero A.E., Farina M., De Leo V., La Marca A., and Cianci A. Clinical, endocrine and metabolic effect of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Hum Reprod 16 (2001) 2066-2072
10. Sonmez A.S., Yasar L., Savan K., Koc S., Ozcan J., Toklar A., et al. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 20 (2005) 175-179
11. Laube H. Acarbose: an update therapeutic use in diabetes treatment. Clin Drug Invest 22 (2000) 141-156
12. Salvatore T., and Giugliano D. Pharmacokinetic-pharmacodynamic relationships of acarbose. Clin Pharmacokinet 30 (1996) 94-106
13. Penna I.A., Canella P.R., Reis R.M., Silva De Sa M.F., and Ferriani R.A. Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study. Hum Reprod 20 (2005) 2396-2401
14. Moghetti P., Tosi F., Castello R., Magnani C.M., Negri C., Brun E., et al. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81 (1996) 952-960
15. Martikainen H., Salmela P., Nuojua-Huttunen S., Perala J., Leinonen S., Knip M., et al. Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil Steril 66 (1996) 564-570
16. Meirow D., Yossipowitch O., and Rosler A. Insulin resistant and nonresistant polycystic ovary syndrome represent two separate clinical and endocrinologic subgroups. Hum Reprod 10 (1995) 1951-1956